COMPASS Pathways and Kings College London publish cognition results from COMP360 psilocybin study in healthy volunteers LONDON, June 03, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in...